Enlivex Therapeutics

(NASDAQ) ENLV

Current Price$0.82

Market Cap$194.60M

Since IPO (2019)-92%

5 Year-93%

1 Year-20%

1 Month-12%

Enlivex Therapeutics Financials at a Glance

Market Cap

$194.60M

Revenue (TTM)

$0.00

Net Income (TTM)

$1.24B

EPS (TTM)

$25.48

P/E Ratio

0.03

Dividend

$0.00

Beta (Volatility)

0.82 (Low)

Dividend

$0.00

Beta (Volatility)

0.82 (Low)

Price

$0.82

Volume

3,123

Open

$0.81

Price

$0.82

Volume

3,123

Open

$0.81

Previous Close

$0.82

Daily Range

$0.80 - $0.82

52-Week Range

$0.66 - $2.10

Dividend

$0.00

Beta (Volatility)

0.82 (Low)

Price

$0.82

Volume

3,123

Open

$0.81

Previous Close

$0.82

Daily Range

$0.80 - $0.82

52-Week Range

$0.66 - $2.10

ENLV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Enlivex Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Oren Hershkovitz, PhD

Website

www.enlivex.com

Headquarters

Ness Ziona, 7403618, IL

ENLV Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

126%

Return on Capital

-1%

Return on Assets

53%

Earnings Yield

33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$194.60M

Shares Outstanding

237.38M

Volume

3.12K

Avg. Volume

565.00K

Financials (TTM)

Gross Profit

$332.00K

Operating Income

$15.00M

EBITDA

$14.67M

Operating Cash Flow

$10.42M

Capital Expenditure

$68.00K

Free Cash Flow

$10.48M

Cash & ST Invst.

$5.87M

Total Debt

$641.00K

Enlivex Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$76.00K

-111.1%

Gross Margin

0.00%

N/A

Market Cap

$194.60M

N/A

Market Cap/Employee

$2.74M

N/A

Employees

N/A

Net Income

$1.24B

+24115.7%

EBITDA

$5.79M

-12.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$5.23M

-77.3%

Accounts Receivable

$235.00K

-82.0%

Inventory

$0.00

N/A

Long Term Debt

$383.00K

+28.1%

Short Term Debt

$258.00K

+9.8%

Return on Assets

53.10%

N/A

Return on Invested Capital

-0.65%

N/A

Free Cash Flow

$2.91M

+29.9%

Operating Cash Flow

$2.90M

+29.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LSTALisata Therapeutics, Inc.

LSTALisata Therapeutics, Inc.$3.12-3.11%

XCURExicure, Inc.

XCURExicure, Inc.$3.36+1.51%

NRSNNeuroSense Therapeutics Ltd.

NRSNNeuroSense Therapeutics Ltd.$0.82+2.23%

CVKDCadrenal Therapeutics, Inc. Common Stock

CVKDCadrenal Therapeutics, Inc. Common Stock$6.67+19.32%

PASGPassage Bio, Inc.

PASGPassage Bio, Inc.$5.11-4.49%

NCNANuCana plc

NCNANuCana plc$2.13+4.41%

GDTCCytoMed Therapeutics Limited

GDTCCytoMed Therapeutics Limited$1.00+0.71%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

AAPLApple

AAPLApple$271.35+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

FFord Motor Company

FFord Motor Company$12.08-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.47+0.05%

Questions About ENLV

What is the current price of Enlivex Therapeutics?

Enlivex Therapeutics is trading at $0.82 per share.

What is the 52-week range for Enlivex Therapeutics?

Over the past 52 weeks, Enlivex Therapeutics has traded between $0.66 and $2.10.

How much debt does Enlivex Therapeutics have?

As of the most recent reporting period, Enlivex Therapeutics reported total debt of $641,000.

How much cash does Enlivex Therapeutics have on hand?

Enlivex Therapeutics reported $2.01M in cash and cash equivalents in its most recent financial results.

What is Enlivex Therapeutics’s dividend yield?

Enlivex Therapeutics does not currently have a dividend yield.

Enlivex Therapeutics

Enlivex Therapeutics Financials at a Glance

ENLV News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Enlivex Therapeutics

ENLV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Enlivex Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ENLV

What is the current price of Enlivex Therapeutics?

What is the 52-week range for Enlivex Therapeutics?

How much debt does Enlivex Therapeutics have?

How much cash does Enlivex Therapeutics have on hand?

What is Enlivex Therapeutics’s dividend yield?

Premium Investing Services